Correlation Between ImmuPharma PLC and Deltex Medical

Can any of the company-specific risk be diversified away by investing in both ImmuPharma PLC and Deltex Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmuPharma PLC and Deltex Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ImmuPharma PLC and Deltex Medical Group, you can compare the effects of market volatilities on ImmuPharma PLC and Deltex Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmuPharma PLC with a short position of Deltex Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmuPharma PLC and Deltex Medical.

Diversification Opportunities for ImmuPharma PLC and Deltex Medical

0.71

Correlation Coefficient

ImmuPharma PLC  Deltex Medical

Poor diversification

The 3 months correlation between ImmuPharma and Deltex is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding ImmuPharma PLC and Deltex Medical Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Deltex Medical Group and ImmuPharma PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmuPharma PLC are associated (or correlated) with Deltex Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Deltex Medical Group has no effect on the direction of ImmuPharma PLC i.e., ImmuPharma PLC and Deltex Medical go up and down completely randomly.

Pair Corralation between ImmuPharma PLC and Deltex Medical

Assuming the 90 days trading horizon ImmuPharma PLC is expected to generate 1.45 times more return on investment than Deltex Medical. However, ImmuPharma PLC is 1.45 times more volatile than Deltex Medical Group. It trades about -0.09 of its potential returns per unit of risk. Deltex Medical Group is currently generating about -0.21 per unit of risk. If you would invest  154.00  in ImmuPharma PLC on September 15, 2024 and sell it today you would lose (39.00) from holding ImmuPharma PLC or give up 25.32% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.48%
Values	Daily Returns

ImmuPharma PLC  vs.  Deltex Medical Group

ImmuPharma PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ImmuPharma PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Deltex Medical Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Deltex Medical Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with ImmuPharma PLC and Deltex Medical

The main advantage of trading using opposite ImmuPharma PLC and Deltex Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmuPharma PLC position performs unexpectedly, Deltex Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Deltex Medical will offset losses from the drop in Deltex Medical's long position.

The idea behind ImmuPharma PLC and Deltex Medical Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.